<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>mCRPC Clinical Handbook (ASCO 2025)</title>

<style>
  body {
    font-family: "Trebuchet MS", sans-serif;
    margin: 0; padding: 0;
    background: #f7f9fb;
    color: #1a1a1a;
    line-height: 1.65;
  }
  header {
    background: #0b3d91;
    color: white;
    padding: 24px 16px;
    text-align: center;
  }
  h1 { margin: 0 0 8px; font-weight: 700; }
  h2 { margin-top: 40px; border-left: 5px solid #0b3d91; padding-left: 10px; }
  h3 { color: #0b3d91; margin-top: 28px; }
  .container { max-width: 900px; margin: auto; padding: 20px; }
  .section-card {
    background: white;
    border-radius: 12px;
    padding: 20px;
    margin: 22px 0;
    box-shadow: 0 2px 6px rgba(0,0,0,0.07);
  }
  .tag {
    display: inline-block;
    padding: 4px 10px;
    border-radius: 8px;
    color: white;
    font-size: 0.85rem;
    margin-right: 6px;
  }
  .arpi { background: #1976d2; }
  .parpi { background: #2e7d32; }
  .taxane { background: #d32f2f; }
  .radio { background: #6a1b9a; }
  .immuno { background: #ff8f00; }
  .other { background: #455a64; }

  .evidence-box {
    background: #eef4ff;
    border-left: 4px solid #0b3d91;
    padding: 10px 14px;
    margin-top: 12px;
    border-radius: 6px;
  }
  .trial {
    font-weight: bold;
    color: #0b3d91;
  }
  footer {
    text-align: center;
    color: #666;
    padding: 22px;
    margin-top: 40px;
  }
</style>
</head>

<body>

<header>
  <h1>mCRPC Clinical Handbook (ASCO 2025)</h1>
  <div>Evidence-informed systemic therapy recommendations with PFS/OS benefits and citations</div>
</header>

<div class="container">

<!-- INTRO -->
<section class="section-card">
  <h2>Introduction</h2>
  <p>
    This clinical handbook summarizes the 2025 ASCO guideline update for 
    <strong>metastatic castration-resistant prostate cancer (mCRPC)</strong>, integrating:
  </p>
  <ul>
    <li>Therapeutic selection based on <strong>prior castration-sensitive phase (CSPC) exposure</strong></li>
    <li><strong>HRR and MSI/MMR biomarkers</strong></li>
